Acceptable mismatching at the class II epitope level: the Canadian experience

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Opinion in Organ Transplantation

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MOT.0000000000000104PMID 24977434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical relevance of the de novo production of anti‐HLA antibodies following intestinal and multivisceral transplantation

  2014cited by this paper
• Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor‐Specific Antibodies

  2013cited by this paper
• Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

  2013cited by this paper
• Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor‐Specific Antibody Development and Improve Outcomes

  2013cited by this paper
• Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

  2012cited by this paper
• Complement‐fixing donor‐specific antibodies identified by a novel C1q assay are associated with allograft loss

  2012cited by this paper
• Posttransplant De Novo Donor‐Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody‐Mediated Rejection

  2012cited by this paper
• Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant

  2012cited by this paper
• Donor‐Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation

  2012cited by this paper
• De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

  2012cited by this paper
• Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

  2011cited by this paper
• Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

  2011cited by this paper
• Natural History of Proteinuria in Renal Transplant Recipients Developing De Novo Human Leukocyte Antigen Antibodies

  2011cited by this paper
• Summary of FDA Antibody‐Mediated Rejection Workshop

  2011cited by this paper
• C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation

  2011cited by this paper
• Long‐term follow up for anti‐HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules

  2011cited by this paper
• Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms

  2011cited by this paper
• HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation.

  2010cited by this paper
• Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.

  2010cited by this paper
• Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

  2010cited by this paper
• De Novo Donor‐Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

  2009cited by this paper
• Identifying Specific Causes of Kidney Allograft Loss

  2009cited by this paper
• Predicting the Immunogenicity of Human Leukocyte Antigen Class I Alloantigens Using Structural Epitope Analysis Determined by HLAMatchmaker

  2008cited by this paper
• Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

  2008cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

  2007cited by this paper
• Simpler and Equitable Allocation of Kidneys From Postmortem Donors Primarily Based on Full HLA-DR Compatibility

  2007cited by this paper
• Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens.

  2007cited by this paper
• Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry.

  2006cited by this paper
• Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African‐American renal transplant cohort

  2006cited by this paper
• A structurally based approach to determine HLA compatibility at the humoral immune level.

  2006cited by this paper
• Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.

  2006cited by this paper
• HLA class I epitopes: A and B loci.

  2006cited by this paper
• Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

  2005cited by this paper
• Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation

  2004cited by this paper
• Critical Evaluation of the Amino Acid Triplet-Epitope Matching Concept in Cadaver Kidney Transplantation.

  2004cited by this paper
• HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION

  2003cited by this paper
• A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants

  2003cited by this paper
• Human leukocyte antigens DR and AB and kidney retransplantation

  2003cited by this paper
• Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1

  2003cited by this paper
• HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1

  2003cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

  2002cited by this paper
• A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients.

  1998cited by this paper

• The New Horizon: A Viewpoint of Novel Drugs, Biomarkers, Artificial Intelligence, and Self-Management in Improving Kidney Transplant Outcomes

  2025cites this paper
• Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.

  2024cites this paper
• Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.

  2023cites this paper
• Antibody-mediated rejection: prevention, monitoring and treatment dilemmas

  2022cites this paper
• Not all eplet mismatches are created equal - A cohort study illustrating implications to long-term graft outcomes.

  2021cites this paper
• Human leukocyte antigen eplet mismatches and long‐term clinical outcomes in pediatric renal transplantation: A pragmatic, registry‐based study

  2020cites this paper
• Eplet-Based HLA Class II Matching for Transplantation: Design of a Repertoire of Interlocus Eplets Shared between HLA-DR, -DQ and -DP Alleles

  2020cites this paper
• Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation

  2018cites this paper
• Epitope-based human leukocyte antigen matching for transplantation: a personal perspective of its future

  2018cites this paper
• Assessment of human leukocyte antigen immunogenicity: current methods, challenges and opportunities

  2018cites this paper
• Sensitization assessment before kidney transplantation.

  2017cites this paper
• Should epitope-based HLA compatibility be used in the kidney allocation system?

  2017cites this paper
• HLA epitope matching in pediatric renal transplantation

  2017cites this paper
• Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?

  2017cites this paper
• Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ eplet map.

  2016cites this paper
• Reflections on HLA Epitope-Based Matching for Transplantation

  2016cites this paper
• Detection of newly antibody‐defined epitopes on HLA class I alleles reacting with antibodies induced during pregnancy

  2016cites this paper
• The Synergistic Effect of Class II HLA Epitope‐Mismatch and Nonadherence on Acute Rejection and Graft Survival

  2015cites this paper
• The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

  2014cites this paper